Skip to Main Content

Author Details

Pavel Hamet
Montreal University Hospital Research Center
1967
526
78
Vardit Ravitsky (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35896277Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.Clin J Am Soc Nephrol2022
35697829Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals.Commun Biol2022
36109108Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.J Am Coll Cardiol2022
33386398SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.Am J Hypertens2021
33539672The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65â¿¿years: Results from the ADVANCE trial.Diabetes Obes Metab2021
33783955Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial.Diabetes Obes Metab2021
33606920Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.Diabetes Obes Metab2021
34719936Theodore Allen Kotchen, MD: June 27, 1938-July 6, 2021.Hypertension2021
34448881Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.Diabetologia2021
34035077The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.Diabetes Care2021
34226943Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.Diabetologia2021
34083270COMMD5 Inhibits Malignant Behavior of Renal Cancer Cells.Anticancer Res2021
33032912Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes.Can J Diabetes2021
33137338Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline.Kidney Int2021
32385604Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.Diabetologia2020
32609422Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.J Diabetes2020
32476250Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study.Diabetes Obes Metab2020
30571562Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.Hypertension2019
31302707The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.Diabetologia2019
31610851Environmental and genetic contributions to diabetes.Metabolism2019
30984108Artificial Intelligence and Machine Learning in Endocrinology and Metabolism: The Dawn of a New Era.Front Endocrinol (Lausanne)2019
31152163A catalog of genetic loci associated with kidney function from analyses of a million individuals.Nat Genet2019
31030606Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.Hypertension2019
31050156Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.Diabetes Obes Metab2019
30817459EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes.J Hypertens2019
31160317Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.Clin J Am Soc Nephrol2019
30551216Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria.Am J Hypertens2019
29308539Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.Diabetologia2018
30021164COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.Cell Rep2018
29731013Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.Can J Cardiol2018
29728717Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.Diabetologia2018
29603537Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.Diabetes Obes Metab2018
27190343Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE.Nephrol Dial Transplant2017
28169881Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.J Hypertens2017
28272517Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene.Sci Rep2017
28449828Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.Can J Cardiol2017
28126242Artificial intelligence in medicine.Metabolism2017
28096151Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity.Am J Hypertens2017
28345607Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na<sup>+</sup> and K<sup>+</sup>: a comparative analysis.Sci Rep2017
29050225HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.Oncotarget2017
29270046No evidence of excessive cancer screening in female noncarriers from <i>BRCA1/2</i> mutation-positive families.Curr Oncol2017
28684396Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.Diabetes Care2017
28060188PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.J Hypertens2017
27787920Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1.Clin Endocrinol (Oxf)2017
27006512Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.Diabetes Care2016
26631737Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.Diabetes2016
26540155Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation.Genet Med2016
26604299ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.Eur J Endocrinol2016
27590190Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.Cardiovasc Diabetol2016
27681243Epigenome and exposome in prenatal programming: essential components of personalized medicine in need of understanding and development.J Hypertens2016
  • 1 - 50 of 526

Recommended Authors

Monash University
Career Start Year 2006
Number of shared co-authors 3
University of Florida
Career Start Year 2001
Number of shared co-authors 1
National Institutes of Health, and Blood Institute
Career Start Year 1994
Number of shared co-authors 0
University of Otago
Career Start Year 1991
Number of shared co-authors 0
Sahlgrenska University Hospital
Career Start Year 1989
Number of shared co-authors 4
UCSI University
Career Start Year 1988
Number of shared co-authors 3
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1988
Number of shared co-authors 105
McGill University
Career Start Year 1987
Number of shared co-authors 84
University of Science and Technology of China
Career Start Year 1987
Number of shared co-authors 0
University Health Network, University of Toronto
Career Start Year 1986
Number of shared co-authors 1
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 0
University of Rome Tor Vergata
Career Start Year 1985
Number of shared co-authors 0
Odense University Hospital
Career Start Year 1985
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1984
Number of shared co-authors 70
and Blood Institute
Career Start Year 1983
Number of shared co-authors 4
and Blood Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 109
Vanderbilt University School of Medicine
Career Start Year 1982
Number of shared co-authors 17
Roy J. & Lucille A. Carver College of Medicine, University of Iowa
Career Start Year 1981
Number of shared co-authors 0
Institute for Genomic Medicine, University of California San Diego
Career Start Year 1978
Number of shared co-authors 23
Vanderbilt University Medical Center
Career Start Year 1978
Number of shared co-authors 0
Georgetown and Howard Universities Center for Clinical and Translational Science
Career Start Year 1976
Number of shared co-authors 12
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 8
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 4
University of California San Diego School of Medicine
Career Start Year 1973
Number of shared co-authors 2
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 1971
Number of shared co-authors 35
Vanderbilt University School of Medicine
Career Start Year 1971
Number of shared co-authors 1
Research Center of the CHU de Quebec-Universite Laval, Universite Laval
Career Start Year 1971
Number of shared co-authors 1
Karolinska Institutet
Career Start Year 1962
Number of shared co-authors 0
Southern Plains Agricultural Research Center, USDA-ARS, College Station
Career Start Year 1960
Number of shared co-authors 1
Research Unit, Skelleftea County Hospital
Career Start Year 1949
Number of shared co-authors 0

Collaborators

Co-authored papers 30
Institute of Cardiovascular Sciences, University College London.
Co-authored papers 25
Co-authored papers 24
University of Toronto, Canada Northern Ontario School of Medicine
Co-authored papers 16
Co-authored papers 16
Co-authored papers 12
Medical College of Wisconsin
Co-authored papers 10
Co-authored papers 7
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Co-authored papers 7
Genomics Research Center
Co-authored papers 7
University of Calgary
Co-authored papers 7
Co-authored papers 6
Hospital Traunstein, University Hospital Regensburg
Co-authored papers 6
University Medicine
Co-authored papers 6
University Medicine Greifswald
Co-authored papers 6
University of Utah
Co-authored papers 6
Co-authored papers 6
Institute of Genetic Epidemiology, Medical Center-University of Freiburg
Co-authored papers 6
University of Regensburg
Co-authored papers 6
Loyola University Medical Center.
Co-authored papers 6
Co-authored papers 6
Institute for Biomedicine (Affiliated to the University of Lubeck)
Co-authored papers 6
University of Regensburg
Co-authored papers 6
Ontario Institute for Cancer Research
Co-authored papers 6
Co-authored papers 6
and Blood Institute
Co-authored papers 6
Co-authored papers 6
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 5
University of Michigan School of Public Health ann arbor
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 5